Correlation Between Vertex Pharmaceuticals and Innovation1 Biotech

Can any of the company-specific risk be diversified away by investing in both Vertex Pharmaceuticals and Innovation1 Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vertex Pharmaceuticals and Innovation1 Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vertex Pharmaceuticals and Innovation1 Biotech, you can compare the effects of market volatilities on Vertex Pharmaceuticals and Innovation1 Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vertex Pharmaceuticals with a short position of Innovation1 Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vertex Pharmaceuticals and Innovation1 Biotech.

Diversification Opportunities for Vertex Pharmaceuticals and Innovation1 Biotech

0.0

Correlation Coefficient

Vertex Pharmaceuticals  Innovation1 Biotech

Pay attention - limited upside

The 3 months correlation between Vertex and Innovation1 is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Vertex Pharmaceuticals and Innovation1 Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovation1 Biotech and Vertex Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vertex Pharmaceuticals are associated (or correlated) with Innovation1 Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovation1 Biotech has no effect on the direction of Vertex Pharmaceuticals i.e., Vertex Pharmaceuticals and Innovation1 Biotech go up and down completely randomly.

Pair Corralation between Vertex Pharmaceuticals and Innovation1 Biotech

Given the investment horizon of 90 days Vertex Pharmaceuticals is expected to generate 53.57 times less return on investment than Innovation1 Biotech. But when comparing it to its historical volatility, Vertex Pharmaceuticals is 40.41 times less risky than Innovation1 Biotech. It trades about 0.04 of its potential returns per unit of risk. Innovation1 Biotech is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  10.00  in Innovation1 Biotech on October 11, 2024 and sell it today you would lose (9.90) from holding Innovation1 Biotech or give up 99.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Vertex Pharmaceuticals  vs.  Innovation1 Biotech

Vertex Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Vertex Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Innovation1 Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Innovation1 Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental drivers, Innovation1 Biotech is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Vertex Pharmaceuticals and Innovation1 Biotech

The main advantage of trading using opposite Vertex Pharmaceuticals and Innovation1 Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vertex Pharmaceuticals position performs unexpectedly, Innovation1 Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovation1 Biotech will offset losses from the drop in Innovation1 Biotech's long position.

The idea behind Vertex Pharmaceuticals and Innovation1 Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.